Patents by Inventor Joseph Mazar

Joseph Mazar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ZIKA VIRUS TREATMENT OF CD24-POSITIVE TUMORS AND DISEASES ASSOCIATED WITH ABNORMAL T CELL ACTIVATION AND TREATING OR PREVENTING ZIKA VIRUS INFECTIONS
    Publication number: 20210322495
    Abstract: CD24-positive malignant and benign tumors are treated by administration of a naturally occurring or modified oncolytic Zika virus. Diseases associated with abnormal T cell activation or T cell-mediated autoimmunity, wherein CD24 expression is increased, are also expected to be treated by administration of a naturally occurring or modified oncolytic Zika virus. Also contemplated are compounds and methods for treating and/or preventing Zika virus infection in a subject.
    Type: Application
    Filed: May 3, 2021
    Publication date: October 21, 2021
    Applicant: THE NEMOURS FOUNDATION
    Inventors: Kenneth Andrew ALEXANDER, Terri Helman FINKEL, Joseph MAZAR, Amy Lynn ROSADO, Jiangfang WANG, Tamarah Jeanette WESTMORELAND
  • Zika virus treatment of CD24-positive tumors and diseases associated with abnormal T cell activation and treating or preventing Zika virus infections
    Patent number: 10993975
    Abstract: CD24-positive malignant and benign tumors are treated by administration of a naturally occurring or modified oncolytic Zika virus. Diseases associated with abnormal T cell activation or T cell-mediated autoimmunity, wherein CD24 expression is increased, are also expected to be treated by administration of a naturally occurring or modified oncolytic Zika virus. Also contemplated are compounds and methods for treating and/or preventing Zika virus infection in a subject.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: May 4, 2021
    Inventors: Kenneth Andrew Alexander, Terri Helman Finkel, Joseph Mazar, Amy Lynn Rosado, Jiangfang Wang, Tamarah Jeanette Westmoreland
  • ZIKA VIRUS TREATMENT OF CD24-POSITIVE TUMORS AND DISEASES ASSOCIATED WITH ABNORMAL T CELL ACTIVATION AND TREATING OR PREVENTING ZIKA VIRUS INFECTIONS
    Publication number: 20190038685
    Abstract: CD24-positive malignant and benign tumors are treated by administration of a naturally occurring or modified oncolytic Zika virus. Diseases associated with abnormal T cell activation or T cell-mediated autoimmunity, wherein CD24 expression is increased, are also expected to be treated by administration of a naturally occurring or modified oncolytic Zika virus. Also contemplated are compounds and methods for treating and/or preventing Zika virus infection in a subject.
    Type: Application
    Filed: August 6, 2018
    Publication date: February 7, 2019
    Applicant: THE NEMOURS FOUNDATION
    Inventors: Kenneth Andrew ALEXANDER, Terri Helman FINKEL, Joseph MAZAR, Amy Lynn ROSADO, Jiangfang WANG, Tamarah Jeanette WESTMORELAND
  • MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMA
    Publication number: 20120108457
    Abstract: Provided herein are methods for the diagnosis of human melanoma by assessing MITF, miR-211, TRPM1, and/or KCNMA1. Methods for treating melanoma are also provided.
    Type: Application
    Filed: October 11, 2011
    Publication date: May 3, 2012
    Inventors: Ranjan Perera, Joseph Mazar